Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUNLUN ENERGY
00135
5
CHINA OILFIELD
02883
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 91.78%-3.29M | ---- | 69.69%-40.03M | ---- | -134.14%-132.06M | ---- | 43.92%-56.4M | ---- | -274.06%-100.58M | ---- |
| Profit adjustment | ||||||||||
| Interest expense - adjustment | 66.62%13.83M | ---- | -7.72%8.3M | ---- | 23.24%8.99M | ---- | 13.84%7.3M | ---- | -67.86%6.41M | ---- |
| Impairment and provisions: | -176.57%-2.41M | ---- | -97.08%3.15M | ---- | 324.27%107.79M | ---- | -76.00%25.41M | ---- | 104.65%105.85M | ---- |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 30.12%216K | ---- |
| -Other impairments and provisions | -176.57%-2.41M | ---- | -97.08%3.15M | ---- | 324.27%107.79M | ---- | -75.95%25.41M | ---- | 105.03%105.63M | ---- |
| Revaluation surplus: | -685.29%-24.51M | ---- | -59.52%4.19M | ---- | -32.50%10.34M | ---- | 0.16%15.33M | ---- | 182.86%15.3M | ---- |
| -Derivative financial instruments fair value (increase) | --100K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other fair value changes | -687.68%-24.61M | ---- | -59.52%4.19M | ---- | -32.50%10.34M | ---- | 0.16%15.33M | ---- | 182.86%15.3M | ---- |
| Depreciation and amortization: | -10.66%6.41M | ---- | 27.69%7.17M | ---- | 69.95%5.62M | ---- | -21.30%3.3M | ---- | -60.35%4.2M | ---- |
| Special items | -99.97%2K | ---- | 315,000.00%6.3M | ---- | 100.08%2K | ---- | -1,622.37%-2.62M | ---- | 82.12%-152K | ---- |
| Operating profit before the change of operating capital | 8.72%-9.97M | ---- | -1,694.74%-10.92M | ---- | 108.91%685K | ---- | -124.78%-7.69M | ---- | 126.63%31.02M | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | 54.44%9.66M | ---- | 793.24%6.25M | ---- | -116.13%-902K | ---- | 143.86%5.59M | ---- | -2,517.86%-12.75M | ---- |
| Accounts receivable (increase)decrease | -55.78%2.16M | ---- | 391.15%4.88M | ---- | 134.54%994K | ---- | -266.74%-2.88M | ---- | 102.16%1.73M | ---- |
| Accounts payable increase (decrease) | 309.99%7.67M | ---- | -47.62%-3.65M | ---- | -124.18%-2.47M | ---- | 39.41%10.23M | ---- | -88.35%7.34M | ---- |
| Financial assets at fair value (increase)decrease | -32.91%265K | ---- | -93.97%395K | ---- | 149.12%6.55M | ---- | -140.29%-13.33M | ---- | 33.65%33.1M | ---- |
| Special items for working capital changes | -14.70%5.27M | ---- | -34.89%6.18M | ---- | 146.82%9.49M | ---- | -12.17%-20.26M | ---- | -127.51%-18.06M | ---- |
| Cash from business operations | 380.61%15.05M | ---- | -78.16%3.13M | ---- | 150.60%14.34M | ---- | -166.89%-28.34M | ---- | 219.37%42.37M | ---- |
| Other taxs | ---- | ---- | ---- | ---- | --153K | ---- | ---- | ---- | 77.80%-285K | ---- |
| Special items of business | ---- | 86.42%-347K | ---- | -940.79%-2.56M | ---- | 101.16%304K | ---- | -289.49%-26.2M | ---- | 165.00%13.83M |
| Net cash from operations | 380.61%15.05M | 86.42%-347K | -78.39%3.13M | -940.79%-2.56M | 151.14%14.49M | 101.16%304K | -167.34%-28.34M | -289.49%-26.2M | 250.98%42.08M | 165.00%13.83M |
| Cash flow from investment activities | ||||||||||
| Purchase of fixed assets | 63.81%-93K | ---- | -34.55%-257K | ---- | 69.73%-191K | ---- | -75.28%-631K | ---- | 92.03%-360K | ---- |
| Cash on investment | 2,299.60%5.93M | ---- | --247K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items in the investment business | ---- | 40.43%-84K | ---- | -2,250.00%-141K | ---- | 82.86%-6K | ---- | 89.06%-35K | ---- | -101.96%-320K |
| Net cash from investment operations | 58,440.00%5.83M | 40.43%-84K | 94.76%-10K | -2,250.00%-141K | 69.73%-191K | 82.86%-6K | -75.28%-631K | 89.06%-35K | -124.06%-360K | -101.96%-320K |
| Net cash before financing | 569.08%20.88M | 84.02%-431K | -78.18%3.12M | -1,005.03%-2.7M | 149.36%14.3M | 101.14%298K | -169.43%-28.97M | -294.23%-26.24M | 209.38%41.72M | 371.27%13.51M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -65.58%3.26M | ---- | 847.20%9.47M | ---- | -94.80%1M | ---- | --19.23M | ---- | ---- | ---- |
| Refund | -5.37%-5.92M | ---- | -58.72%-5.62M | ---- | ---3.54M | ---- | ---- | ---- | 38.66%-21.16M | ---- |
| Interest paid - financing | -159.63%-11.74M | ---- | 42.46%-4.52M | ---- | -12.77%-7.86M | ---- | 6.61%-6.97M | ---- | 11.94%-7.46M | ---- |
| Other items of the financing business | ---- | -3.88%-4.91M | ---- | 45.14%-4.72M | ---- | -156.83%-8.61M | ---- | 173.47%15.15M | ---- | -18.39%-20.62M |
| Net cash from financing operations | -172.71%-21.39M | -3.88%-4.91M | 53.96%-7.84M | 45.14%-4.72M | -386.14%-17.04M | -156.83%-8.61M | 116.37%5.95M | 173.47%15.15M | -41.22%-36.36M | -18.39%-20.62M |
| Effect of rate | -300.00%-6K | -66.67%1K | -99.02%3K | -99.01%3K | 317.73%307K | 288.20%303K | 22.10%-141K | 22.60%-161K | -1,005.00%-181K | -1,980.00%-208K |
| Net Cash | 89.22%-509K | 28.08%-5.34M | -72.62%-4.72M | 10.72%-7.42M | 88.11%-2.74M | 25.09%-8.31M | -529.48%-23.02M | -56.09%-11.09M | 143.70%5.36M | 68.26%-7.11M |
| Begining period cash | -32.73%9.7M | -32.73%9.7M | -14.42%14.42M | -14.42%14.42M | -57.88%16.85M | -57.88%16.85M | 14.87%40.01M | 14.87%40.01M | -26.01%34.83M | -26.01%34.83M |
| Cash at the end | -5.31%9.19M | -37.67%4.37M | -32.73%9.7M | -20.78%7.01M | -14.42%14.42M | -69.24%8.84M | -57.88%16.85M | 4.50%28.75M | 14.87%40.01M | 11.54%27.51M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.